Searchable abstracts of presentations at key conferences in endocrinology

ea0011p72 | Clinical case reports | ECE2006

Regression of somatotropinoma in the course of treatment with octreotide in a female patient with acromegaly

Matuszek B , Lenart-Lipiska M , Nowakowski A

Long-acting somatostatin analogs are now increasingly being prescribed as adjuvant and primary therapy for the treatment of acromegaly. Many studies have shown them to be both effective and safe, by suppressing GH levels and normalizing serum IGF-1 levels in most cases.The aim of the study was to analyze the case report of a female patient with active acromegaly and evaluate the efficacy of long-acting synthetic analog of somatostatin (Sandostatin LAR) for biochemical control ...

ea0011p582 | Neuroendocrinology and behaviour | ECE2006

Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors

Matuszek B , Obel E , Kowalczyk M , Nowakowski A

Introduction: Hypopituitary patients receiving conventional hormone substitution, but without GH replacement, have an increased mortality from cardiovascular diseases. Inadequate hormone replacement is a possible cause of this increased mortality. GH deficiency in adult patients has been associated with several cardiovascular risk factors, including hyperlipidemia, increased abdominal adiposity, and impaired insulin sensitivity.Aim of the study: The aim ...

ea0029p592 | Diabetes | ICEECE2012

Comparative analysis of adiponectin isoforms distribution in pregnant women with gestational diabetes mellitus and after delivery

Matuszek B. , Burska A. , Leszczynska-Gorzelak B. , Donica H. , Nowakowski A.

Objective: The aim of the study was to evaluate distribution of circulating adiponectin (AdipoQ) isoforms at pregnant women with gestational diabetes mellitus (GDM) and comparison analysis of isoform distribution changes 12 months after delivery.Design: The study was conducted on 64 pregnant women who underwent routine pre-natal tests for GDM between 24 and 28 week of gestation and 30 of them 12 months after delivery. The study group included 36 women di...

ea0029p591 | Diabetes | ICEECE2012

Adiponectin among markers of low grade inflammation in gestational diabetes mellitus

Matuszek B. , Burska A. , Malecha-Jedraszek A. , Lenart-Lipinska M. , Nowakowski A. , Donica H.

Background and aims: The subclinical inflammation connected with hypoadiponectinaemia and inflammatory pattern may favor the development of gestational diabetes mellitus (GDM).Methods: In total, 66 pregnant women were enrolled in the study during systematic testing for GDM between 24 and 28 weeks of gestation. GDM was diagnosed in 42 cases, 24 were normal glucose tolerant control group (NGT). In blood serum concentration of glucose, insulin, adiponectin ...